4
Changes in Ownership
Acumen Pharmaceuticals, Inc. Filed Acc 0001576885-25-000031
Chief Operating Officer sold 2,914 shares at $1.61 ($4,692)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barton Russell Chief Operating Officer | 2025-01-21 | Sale 10b5-1 | −2,914 | $1.61 | $4,692 | 136,117 | D |
| Open-market sales · 2,914 sh · avg $1.61 · $4,692 | |||||||
Loading xslF345X05/wk-form4_1737670478.xml…